Market revenue in 2022 | USD 5.7 million |
Market revenue in 2030 | USD 10.6 million |
Growth rate | 8% (CAGR from 2022 to 2030) |
Largest segment | Blood culture media |
Fastest growing segment | Assay Kits & Reagents |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Blood culture media was the largest segment with a revenue share of 38.6% in 2022. Horizon Databook has segmented the UAE sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
The UAE government has taken several initiatives to improve diagnosis & management of sepsis in the country. In 2019, the Ministry of Health and Prevention launched the “Sepsis Prevention and Management Program” to raise awareness about sepsis, improve the quality of care for patients with sepsis, and reduce the morbidity & mortality associated with the condition.
The growth of UAE’s sepsis diagnostics market can be attributed to ongoing government initiatives to prevent sepsis-related deaths and the high prevalence of infectious diseases. According to data published by the Journal of Pediatrics & Neonatal Care in March 2018, sepsis was one of the most common diseases in the neonatal period, with significant morbidity and mortality rate.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account